Nasus Pharma Ltd.
About
3.36USD+0.16 +5.00%
Closed • Updated at 06:04 GMT+00:00Market Cap$28.94M
Volume290.3K
Beta1.30
RSI59.86
Nasus Pharma Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 25 2026
Nasus Pharma Advances NS002 Towards Pivotal Study Following Positive Phase 2; Reports Annual Results and Provides Business Update
Mar 16 2026
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold
Mar 9 2026
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study
Mar 9 2026
Nasus Pharma to Present and Participate in the Upcoming Life Sciences Investor Forum
Feb 20 2026
Nasus Pharma to Participate in Upcoming Investor Conferences
Community Chat
Ask AI
Try asking